Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

100%

6 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3

5(83.3%)

Phase 4

1(16.7%)

6Total

Phase 3(5)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04024163Phase 3Active Not Recruiting

Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease

Role: collaborator

NCT06019533Phase 3Completed

A Trial of Efficacy, Safety and Tolerability of LVDS (Levonorgestrel Vaginal Delivery System) During 13 Cycles

Role: lead

NCT05303636Phase 4Active Not Recruiting

LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

Role: collaborator

NCT06389474Phase 3Recruiting

Efficacy of INM004 in Children With STEC-HUS

Role: collaborator

NCT05461573Phase 3Completed

Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females

Role: collaborator

NCT03945513Phase 3Completed

A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles

Role: collaborator

All 6 trials loaded